Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
CNS Refresh: Boehringer's New Approach To Tricky Neuropsychiatry Diseases
Nov 13 2017
•
By
Lucie Ellis-Taitt
Boehringer believes advances in CNS scientific understanding mean pharma needs a new approach • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Neurological
More from Therapeutic Category